| _creationDate | May 23, 2023 |
| _modificationDate | December 9, 2024 |
| _creator | Kx601 |
| _fullText | {{ServiceRequestCase
|requisition=Current Concepts in Head and Neck and Endocrine Pathology
|subject=MGH
|intent=order
|occurrenceDateTime=2023/06/09 05:00
|basedOn=WSI23-88
|priority=routine
|code=study
|orderDetail=case
|authoredOn=May 23, 2023 05:15:30 PM
|requester=Kx601
|locationCode=learn
|seq ... |
| _numRevisions | 2 |
| _isRedirect | No |
| identifier | WSI23-88-Case-8 |
| basedOn | WSI23-88 |
| requisition | Current Concepts in Head and Neck and Endocrine Pathology |
| intent | order |
| category | null |
| priority | routine |
| code | study |
| orderDetail | case |
| subject | MGH |
| occurrenceDateTime | June 9, 2023 5:00:00 AM |
| authoredOn | May 23, 2023 5:15:30 PM |
| requester | Kx601 |
| performer | pms36 |
| locationCode | learn |
| reasonCode | 33 year old diagnosed with papillary thyroid carcinoma in 2012. Lesion was a 2.0 cm in the right lobe with minimal extrathyroidal extension and two negative lymph nodes (currently would have been classified as pT1b N0a -- then pT3 N0). All was fine until July 2020 noted to have LUL lung lesion excised and RUL lung lesion excised Aug 2020. Jan 2021 • noted to have two brain lesions (L frontoparietal and R occipital). Tumor noted to have CCDC149-ALK fusion. Subsequently treated with SAS (stereotactic ablative surgery -- gamma knife). Now alectinib. |
| supportingInfo | Kinase fusion-related thyroid carcinoma (for now • associated with classical papillary thyroid carcinoma). Alectinib targets ALK (anaplastic lymphoma kinase) |
| specimen | null |
| bodySite | Thyroid |
| sequence | 8 |
| access | private |
| identifier | WSI22-66-Case-1_1 |
| basedOn | WSI23-88-Case-8 |
| partOf | WSI23-88 |
| status | completed |
| type | image |
| modality | mrxs |
| view | show |
| createdDateTime | May 23, 2023 5:15:30 PM |
| operator | Kx601 |
| reasonCode | H&E |
| bodySite | null |
| frames | 1 |
| content | WSI22-66-Case-1_1.mrxs |
| note | null |
| subject | Z0FBQUFBQmtiUFRzczUxbWtKM1o1cEozRFZHMjNHdzBzY1RuUmZ1VGpOZWFTaHhwdlkwTmk3TEZIRU4xajd0d241VlFKRWtSaV9ua2RkbVdILWRoRmJFQW1oU2ExT0dmSkE9PQ |
| identifier | WSI22-66-Case-1_2 |
| basedOn | WSI23-88-Case-8 |
| partOf | WSI23-88 |
| status | completed |
| type | image |
| modality | mrxs |
| view | show |
| createdDateTime | May 23, 2023 5:15:30 PM |
| operator | Kx601 |
| reasonCode | H&E |
| bodySite | null |
| frames | 2 |
| content | WSI22-66-Case-1_2.mrxs |
| note | null |
| subject | Z0FBQUFBQmtiUFVkUWRJZS1iVHFGbmdic3BWcVlZNkh4cVpncGtDSkh4amt4SmNsVWdqQlVmSXNDWTRLd1V1VzhKb214endHSDNqQU16UWh3UHFBTXI1TzhBTGJJREp5b1NJNTBmMVgwRVFSMlpWMlAtZnBzMms9 |
| identifier | WSI22-66-Case-1_3 |
| basedOn | WSI23-88-Case-8 |
| partOf | WSI23-88 |
| status | completed |
| type | image |
| modality | mrxs |
| view | show |
| createdDateTime | May 23, 2023 5:15:30 PM |
| operator | Kx601 |
| reasonCode | H&E |
| bodySite | null |
| frames | 3 |
| content | WSI22-66-Case-1_3.mrxs |
| note | null |
| subject | Z0FBQUFBQmtiUFVsdGJZQ0JfQWFvVWNpajZsQWczYVJnVHBOYkxvZ2xYb3o1MlRRbFg1SWp2RFN4dzRVTlVwdktlOEdGaTJmWks0aWl3NTI5TjNmNURYdE4tZWR1ZDRHOXdTXzQ5bTdZeDNtSmpmY1JmVGRXSm89 |
| identifier | WSI22-66-Case-1_4 |
| basedOn | WSI23-88-Case-8 |
| partOf | WSI23-88 |
| status | completed |
| type | image |
| modality | mrxs |
| view | show |
| createdDateTime | May 23, 2023 5:15:30 PM |
| operator | Kx601 |
| reasonCode | H&E |
| bodySite | null |
| frames | 4 |
| content | WSI22-66-Case-1_4.mrxs |
| note | null |
| subject | Z0FBQUFBQmtiUFVtQ0M3U1BuazJFQURDTVNFQ1lpOWk3TUNtM0E3TUtkcXlsZ0ZZdF9pUkRzaVJ3Tlg0RDNGekgwUjJHMVZxcHhTcXVpUEZBZTZhYWhwMUV0dVltT21PNEE9PQ |
